Valida Health appoints Titus Gylvin as Chief Executive Officer

PRESS RELEASE – Copenhagen, Denmark, May 4th, 2021

Valida Health appoints Titus Gylvin as Chief Executive Officer Valida Health, a fast-growing Healthtech company and an active player within COVID-19 prevention, testing, diagnosis, monitoring and management of the disease, today announced that Titus Gylvin, MD, PhD will join the company as Chief Executive Officer, effective as of May 1, 2021.

Titus Gylvin CEO

CEO Background:

Titus Gylvin joins Valida Health after almost 14 years outside Denmark, with the last 10 years at Roche Pharmaceuticals and prior to this in Novo Nordisk.

Mr. Gylvin has a strong track record in launching and commercializing a broad range of products with a deep knowledge of the patient journey, market access, and payer dynamics in Europe, China and the US.

During his 20 years in the biotech/pharmaceutical industry he has held several leadership positions in both strategic and operational roles across the value chain in global pharma and research. Titus initiated and accelerated large-scale strategic transformations and has proven experience in building high performing teams across cultures and functions. He is passionate about creating a culture of innovation and making a positive difference for people and societies in need.

He successfully established large scale public-private partnerships with leading healthcare Institutions in several European countries and has launched a broad range of products and healthcare solutions in challenging markets, making him an ideal candidate to lead Valida Health further as it expands its digital solutions and health offerings across Europe and globally.

A physician-business leader with a broad range of medical and commercial experience Titus Gylvin received his medical degree from the Copenhagen University, holds a Ph.D. in genetics (diabetes and obesity) from Steno Diabetes Center and is
an alumni at Harvard Business School.

Commented by Christian Scherfig

“Attorney and Chairman of the Advisory Board at Valida Health, Christian Scherfig, states “I am very pleased to announce that Titus Gylvin will join the leadership team as Chief Executive Officer starting May 4th, 2021. This is a key moment for Valida Health, with multiple near-term milestones that will further define the company’s future direction. In our search we have been looking for an experienced leader who can support our near-term execution and align the company around a strategic vision for our long-term growth ambitions and international presence. With his strong track record on growth over the past two decades in relevant roles, Mr. Gylvin will bring his positive leadership and broad international experience to successfully shape our organization as we prepare for the further expansion into new markets and accelerate our Valida Healthtech Platform based solutions to healthcare’s most pressing challenges while improving customer experience”.

Commented by Titus Gylvin

“Titus Gylvin states “I’m very excited to be joining Valida Health, at such a pivotal time. Not only due to its significant results and potential but also the incredible near-term opportunities to create further impact for customers, companies and societies. The COVID-19 pandemic has more than ever, demonstrated how a Healthtech company like Valida Health with its expertise and technology can bring fast scalable solutions in times of need.” said Titus Gylvin. “Building on the learnings that I have gained from my medical and commercial leadership roles across the globe, I look forward to joining this unique and fast paced team to further advance the mission and bring new scalable digital technologies to market. I am also very much looking forward to be back in Denmark after so many years away.”

About Valida Health

Valida Health is a Danish fast growing Healthtech company that brings expert advice and services to generate information and data that are critical for the prevention, diagnosis, treatment, monitoring and management of health and lifestyle. It´s unique Valida Healthtech Platform has full interoperability to other IT systems in companies or countries and is scalable according to whatever need. The Valida Healthtech Platform can be tailored to any individual health challenge, customer or society need and provides complete and reliable health solutions at your fingertips to meet the users’ needs. During the COVID-19 pandemic it is used and serves in all of the Nordics, key European countries and is being rolled out in part of Asia soon. Valida Health operates in 14 counties.

For further information please contact:

Press officer Ann Sophie Friis on mobile +45 3134 1971 or by e-mail annsophie@validahealth.dk